FDA approves non-opioid analgesic forte.
-
Last Update: 2020-07-27
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Galt Pharmaceuticals, !----, has approved a new drug application for its non-opioid analgesic forte, a non-opioid analgesic drug, approved by the U.SFood and Drug Administrationphoto source: Orphenadrine Forte(Orphenadrine Citrate, aspirin and caffeine 50mg/770 mg/60mg) Indications include: 1Reducing mild to moderate pain from acute musculoskeletal disease2As an aid to rest, physiotherapy and other measures to relieve acute painBarry Patel, ceo and co-founder of, said: "This is a huge victory in the fight against opioids in the United States, and the FDA's swift action confirms the seriousness of the problem" the Centers for Disease Control and Prevention reports that 20 percent of U.Sadults suffer from chronic pain -- one of the most common reasons adults seek medical careOrphenadrine's role has not been clearly determined, but may be related to its analgesic effectOrpheusic Forte tablets do not directly relax the strained muscles.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
